1. Home
  2. NOMD vs HROW Comparison

NOMD vs HROW Comparison

Compare NOMD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$11.33

Market Cap

1.4B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$45.07

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOMD
HROW
Founded
2014
1998
Country
United Kingdom
United States
Employees
N/A
373
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NOMD
HROW
Price
$11.33
$45.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$12.50
$69.86
AVG Volume (30 Days)
1.3M
855.5K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$31.62
Revenue Next Year
$1.45
$50.77
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.99
$28.54
52 Week High
$18.33
$54.98

Technical Indicators

Market Signals
Indicator
NOMD
HROW
Relative Strength Index (RSI) 65.52 65.44
Support Level $11.04 $44.30
Resistance Level $12.36 $51.01
Average True Range (ATR) 0.34 2.24
MACD 0.08 0.32
Stochastic Oscillator 82.68 78.83

Price Performance

Historical Comparison
NOMD
HROW

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: